Arcturus Therapeutics Holdings Inc. · NASDAQ:ARCT
Federated Hermes, Inc. reported a 11.63% stake in Arcturus Therapeutics Holdings Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 8, 2026
Federated Hermes, Inc. reported a 11.63% stake in Arcturus Therapeutics Holdings Inc., 3,303,640 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 11.63%
- Shares
- 3,303,640
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Federated Hermes, Inc. | 11.63% | 3,303,640 |
| Voting Shares Irrevocable Trust | 11.63% | 3,303,640 |
| Thomas R. Donahue | 11.63% | 3,303,640 |
| Ann C. Donahue | 11.63% | 3,303,640 |
| J. Christopher Donahue | 11.63% | 3,303,640 |
Source
Related
- Arcturus Therapeutics Holdings Inc.
- Federated Hermes, Inc.
- Arcturus Therapeutics Holdings Inc. shareholders
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · ARK Investment Management LLC · May 7, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Feb 17, 2026
- Schedule 13G/A · ARK Investment Management LLC · Feb 3, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Nov 14, 2025